中/EN
中文繁體
English
Investor Relations
IR Home
Corporate Overview
Financial Highlights
Financial Reports
ESG Reports
Regulatory Filings
Press Releases
Company Presentations
Stock Quotes & Charts
Analyst Coverage
FAQs
IR Contact
Corporate
Investor Relations
IR Home
Corporate Overview
Financial Highlights
Financial Reports
ESG Reports
Regulatory Filings
Press Releases
Company
Presentations
Stock Quotes &
Charts
Analyst Coverage
FAQs
IR Contact
Latest News
JAN
22
APPROVAL FOR CLINICAL TRIAL OF UBT251 INJECTION ON INDICATION OF CHRONIC KIDNEY DISEASE
JAN
06
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2024
JAN
03
List of Directors and Their Role and Function
2024
Interim Report
PDF
ESG Report 2023
Environment
Social
Governance
Presentation
Investor Information
Regulatory Filings
Corporate Governance
Stock Quotes & Charts
FAQs
IR Contact
Address
6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong
Email
tulir@tul.com.hk
